DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
|
|
- Franklin Wilkinson
- 5 years ago
- Views:
Transcription
1 DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS BIO067B July 2014 Jon Evans Project Analyst ISBN: BCC Research 49 Walnut Park, Building 2 Wellesley, MA USA (toll-free within the USA), or (+1) information@bccresearch.com
2 TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 2 STUDY GOALS AND OBJECTIVES 2 REASONS FOR DOING THE STUDY 2 INTENDED AUDIENCE 3 SCOPE OF REPORT 3 TABLE A SCOPE OF REPORT 3 METHODOLOGY 4 INFORMATION SOURCES 4 RELATED BCC RESEARCH REPORTS 4 ANALYST CREDENTIALS 4 BCC RESEARCH WEBSITE 4 DISCLAIMER 5 CHAPTER 2 SUMMARY 7 SUMMARY TABLE GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, SUMMARY FIGURE GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, ($ MILLIONS) 7 7 CHAPTER 3 OVERVIEW 11 INTRODUCTION 11 DNA VACCINE TECHNOLOGIES COVERED IN THIS REPORT 11 TABLE 1 SCOPE OF THIS REPORT 11 GLOBAL MARKET FOR DNA VACCINES 12 TABLE 2 GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS) TABLE 3 GLOBAL VALUE OF HUMAN DNA VACCINE MARKET BY INDICATION, FORCES DRIVING DNA VACCINE MARKET GROWTH 13 TABLE 4 DNA VACCINE INDUSTRY GROWTH DRIVING FORCES 13 LIFE CYCLE STATUS OF DNA VACCINE TECHNOLOGIES 14 TABLE 5 LIFE CYCLE STAGE OF VACCINE TYPES 14 COMMERCIAL STATUS OF DNA VACCINE TECHNOLOGIES 14 TABLE 6 COMMERCIAL STATUS OF DNA VACCINES 14 DNA VACCINE INDUSTRY 15 TABLE 7 DNA VACCINE INDUSTRY STRUCTURE CHAPTER 4 DNA VACCINE TECHNOLOGIES 18 HISTORY 18 TABLE 8 DNA VACCINE HISTORY 19 THE HUMAN IMMUNE SYSTEM 20 TABLE 9 COMPONENTS OF THE IMMUNE SYSTEM 20 VACCINES 22 VACCINE EVOLUTION 22 FIGURE 1 EVOLUTION OF VACCINE TECHNOLOGIES 22 VACCINE TYPES 23
3 TABLE 10 VACCINE TYPES 23 Technology Life Cycle Stage of Vaccine Types 24 TABLE 11 TECHNOLOGY LIFE CYCLE STAGE OF VACCINE TYPES 24 DNA VACCINES 25 INTRODUCTION 25 FIGURE 2 MECHANISM OF ACTION OF A DNA VACCINE 25 CHANGING VACCINE PARADIGM 26 TABLE 12 CHANGING VACCINE PARADIGM 26 TABLE 13 ADVANTAGES AND DISADVANTAGES OF DNA VACCINES 27 FIGURE 3 SAFETY AND EFFICACY PROFILE OF DNA VERSUS VIRAL-VECTOR VACCINES FUNCTION AND SCOPE OF DNA VACCINES 29 FIGURE 4 DNA VACCINE FUNCTION AND MARKET SCOPE 29 TABLE 14 EMERGING COMPETITIVE LANDSCAPE FOR DNA VACCINES 31 CANCER DNA VACCINES 31 TABLE 15 CANCER VACCINE TYPES 32 DNA VACCINE TECHNOLOGY VALUE CHAIN 33 FIGURE 5 DNA VACCINE TECHNOLOGY VALUE CHAIN 33 TABLE 16 TECHNOLOGY DRIVERS FOR DNA VACCINE VALUE CHAIN 34 Antigen Discovery 35 Plasmid Design 35 TABLE 17 PLASMID DESIGN OBJECTIVES 35 TABLE 18 WAYS TO OPTIMIZE MAMMALIAN GENE EXPRESSION IN PLASMID DNA 36 Plasmid Manufacture 37 FIGURE 6 CONVENTIONAL AND PLASMID DNA VACCINE PRODUCTION PROCESS 38 TABLE 19 DNA PLASMID QUALITY COMPARISON 38 Delivery Technologies 39 TABLE 20 COMPARISON OF DNA DELIVERY TECHNOLOGIES 39 Uncomplexed pdna 39 Electroporation 40 FIGURE 7 EP PROCESS SCHEMATIC 41 Liposomes 41 Gold Particles 42 Nanoparticles 42 Bacterial Ghosts 43 Bacteriophages 43 Viruses 43 TABLE 21 IN VIVO VIRAL VECTOR TECHNOLOGIES COMPARED 44 Targeting Technologies 45 FIGURE 8 STRATEGIES FOR TARGETING DENDRITIC CELLS 46 Adjuvant Technologies 46 TABLE 22 DNA VACCINE ADJUVANT TECHNOLOGIES 46 DNA VACCINE TECHNOLOGY NEEDS 47 TABLE 23 TECHNOLOGY NEEDS FOR DNA VACCINES CHAPTER 5 DNA VACCINE APPLICATIONS 51 RESEARCH TOOL APPLICATIONS 51 CLINICAL APPLICATIONS 51
4 OVERVIEW TO DNA VACCINE CLINICAL TRIALS PROCESS 51 TABLE 24 DNA VACCINE DEVELOPMENT FLOW SHEET 52 TABLE 25 DNA VACCINE PRECLINICAL DEVELOPMENT STEPS 53 FIGURE 9 FUTURE VACCINE CLINICAL TRIALS OVERVIEW 53 DNA VACCINE CLINICAL TRIALS SUMMARY 55 TABLE 26 DNA VACCINES CLINICAL TRIALS SUMMARY BY STARTING YEAR, AS OF APRIL 2014 TABLE 27 DNA VACCINE CLINICAL PHASE I TRIALS SUMMARY, AS OF APRIL TABLE 28 DNA VACCINE CLINICAL PHASE I/II TRIALS SUMMARY, AS OF APRIL TABLE 29 DNA VACCINE CLINICAL PHASE II TRIALS SUMMARY, AS OF APRIL TABLE 30 DNA VACCINE CLINICAL PHASE II/III TRIALS SUMMARY, AS OF APRIL TABLE 31 DNA VACCINE CLINICAL PHASE III TRIALS SUMMARY, AS OF APRIL TABLE 32 DNA VACCINE CLINICAL PHASE IV TRIALS SUMMARY, AS OF APRIL CANCER DNA VACCINE CLINICAL TRIALS 65 TABLE 33 DNA VACCINE CANCER CLINICAL TRIALS SUMMARY, AS OF APRIL Melanoma 67 INFECTIOUS DISEASE DNA VACCINES 68 TABLE 34 INFECTIOUS DISEASES DNA VACCINES CLINICAL TRIALS, AS OF APRIL 2014 HSV 73 HPV 73 Influenza 74 HBV 75 Japanese Encephalitis 76 CMV 76 HIV 77 ALLERGY AND AUTOIMMUNE DISEASE 78 TABLE 35 INFECTIOUS DISEASES DNA VACCINES CLINICAL TRIALS, AS OF APRIL 2014 BIODEFENSE DNA VACCINES 78 ANIMAL HEALTH DNA VACCINES CHAPTER 6 DNA VACCINE INDUSTRY 82 VACCINE INDUSTRY STRUCTURAL SHIFTS 82 TABLE 36 VACCINE INDUSTRY STRUCTURAL SHIFTS 82 INDUSTRY STRUCTURE 83 TABLE 37 VACCINE INDUSTRY STRUCTURE: TRADITIONAL VERSUS EMERGING 83 FIGURE 10 MARKETING OF APPROVED VACCINES IN THE UNITED STATES, 2014 (%) 84 TABLE 38 COMPARISON OF VACCINES AND PHARMACEUTICALS BUSINESSES 85 DNA VACCINE INDUSTRY COMPETITORS 87 TABLE 39 DNA VACCINE INDUSTRY COMPETITOR POSITION 87 DNA VACCINE COMMERCIAL VALUE CHAIN 88 FIGURE 11 DNA VACCINE COMMERCIAL VALUE CHAIN 89 DNA VACCINE COMPETITOR STRATEGIC POSITIONING 89 TABLE 40 LARGE PHARMA VACCINE COMPANY STRATEGIC FOCUS 89 TABLE 41 INTEGRATED BIOTECHNOLOGY COMPANY STRATEGIC FOCUS 90 TABLE 42 INTEGRATED BIOTECHNOLOGY COMPANY STRATEGIC MARKET FOCUS 91 TABLE 43 SPECIALIZED BIOTECHNOLOGY COMPANY STRATEGIC FOCUS 93
5 RESEARCH & DEVELOPMENT FOCUS 94 TABLE 44 ASTELLAS PHARMA INC. OPEN CLINICAL TRIALS, AS OF APRIL TABLE 45 BAVARIAN NORDIC OPEN CLINICAL TRIALS, AS OF APRIL TABLE 46 BEIJING CENTER FOR DISEASE CONTROL AND PREVENTION; MUNICIPAL SCIENCE & TECHNOLOGY COMMISSION OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 47 CITY OF HOPE MEDICAL CENTER, NATIONAL CANCER INSTITUTE (NCI) OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 48 DYNAVAX TECHNOLOGIES CORPORATION OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 49 GLAXOSMITHKLINE OPEN CLINICAL TRIALS, AS OF APRIL TABLE 50 IMPERIAL COLLEGE LONDON OPEN CLINICAL TRIALS, AS OF APRIL TABLE 51 MERCK SHARP & DOHME OPEN CLINICAL TRIALS, AS OF APRIL TABLE 52 NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 53 NATIONAL TAIWAN UNIVERSITY HOSPITAL OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 54 SANOFI OPEN CLINICAL TRIALS, AS OF APRIL TABLE 55 SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 56 U.S. ARMY MEDICAL RESEARCH OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 57 UNIVERSITY OF COLORADO OPEN CLINICAL TRIALS, AS OF APRIL TABLE 58 UNIVERSITY OF OXFORD OPEN CLINICAL TRIALS, AS OF APRIL TABLE 59 UNIVERSITY OF WISCONSIN OPEN CLINICAL TRIALS, AS OF APRIL INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES 100 TABLE 60 INDUSTRY ACQUISITIONS AND MERGERS, TABLE 61 DNA VACCINE STRATEGIC ALLIANCES CHAPTER 7 DNA VACCINE MARKETS 105 GROWTH DRIVING FORCES 105 TABLE 62 DNA VACCINE INDUSTRY GROWTH DRIVING FORCES 105 MARKET FORECASTS 106 OVERVIEW 106 TABLE 63 GLOBAL VALUE OF PHARMACEUTICAL MARKET BY TYPE, THROUGH 2019 ($ MILLIONS) DNA VACCINE MARKETS BY END USE 107 TABLE 64 GLOBAL VALUE OF DNA VACCINES BY END USE, THROUGH 2019 ($ MILLIONS) DNA VACCINE RESEARCH TOOLS MARKETS 108 TABLE 65 GLOBAL VALUE OF DNA VACCINES RESEARCH TOOLS MARKET BY APPLICATION, DNA VACCINE CLINICAL MARKETS 108 TABLE 66 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY APPLICATION, Strategic Positioning 109 FIGURE 12 DNA VACCINE STRATEGIC MARKET GRID 109 Allergies 110 TABLE 67 DNA VACCINE ALLERGY MARKET OPPORTUNITIES 110 Cancer Therapeutics 110 TABLE 68 CAUSE OF DEATH, WORLDWIDE, 2004 AND 2030 (% OF ALL DEATHS)
6 Infectious Diseases 111 DNA CANCER VACCINES MARKET 111 TABLE 69 GLOBAL VALUE OF CANCER CLINICAL DNA VACCINES BY INDICATION, TABLE 70 DNA VACCINE CANCER MARKET OPPORTUNITIES 112 Melanoma 114 Solid Tumors (Including Ovarian, Breast and Small-Cell Lung Cancer) 114 Pancreatic Cancer 114 INFECTIOUS DISEASE DNA VACCINE MARKETS 114 TABLE 71 GLOBAL VALUE OF INFECTIOUS DISEASE CLINICAL DNA VACCINES MARKET BY INDICATION, CMV 115 HBV 116 HPV 116 HCV 117 HIV 117 ANIMAL HEALTH DNA VACCINE MARKETS 118 TABLE 72 GLOBAL VALUE OF ANIMAL HEALTH CLINICAL DNA VACCINES MARKET, BY INDICATION, Canine Melanoma 119 Equine West Nile Virus 119 Leishmaniasis 119 Feline Leukemia Virus 120 Fish Vaccine Adjuvants 120 BIODEFENSE DNA VACCINE MARKETS 120 TABLE 73 GLOBAL VALUE OF BIODEFENSE CLINICAL DNA VACCINES MARKET, BY END USE, DNA VACCINE MARKETS BY DELIVERY TECHNOLOGY 123 TABLE 74 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY DELIVERY TECHNOLOGY, DNA VACCINE MARKET BY FORMAT AND FUNCTION 124 TABLE 75 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY VACCINE FORMAT, TABLE 76 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY FUNCTION, DNA VACCINES MARKET BY GEOGRAPHICAL REGION 125 TABLE 77 GLOBAL VALUE OF DNA VACCINES MARKET, BY GEOGRAPHICAL REGION, CHAPTER 8 COMPANY PROFILES 128 ADIMMUNE 128 ADVANCED BIOSCIENCE LABORATORIES INC. 128 ALDEVRON LLC 129 ALTEA THERAPEUTICS 129 ALTHEA TECHNOLOGIES INC. 130 ANGES MG INC. 130 AVAX TECHNOLOGIES 131 BAVARIAN NORDIC A/S 131 BIGDNA, LTD. 132
7 BIOJECT MEDICAL TECHNOLOGIES INC. 133 BTX HARVARD APPARATUS 134 CHANGCHUN BAIKE PHARMACEUTICAL CO. LTD. 134 CHRONTECH PHARMA 134 COBRA BIOMANUFACTURING PLC 135 CRUCELL 136 CYTRX CORP. 137 DENDREON CORP. 137 DYNAVAX TECHNOLOGIES 138 EUROVACC FOUNDATION, THE 138 FIT BIOTECH OYJ PLC 139 GENEART AG 140 GENETIC IMMUNITY 141 GENEXINE 142 GENOMIDEA INC. 143 GENOVAC GMBH 144 GENVEC INC. 145 GEOVAX LABS 145 GLAXOSMITHKLINE 146 GREENPAK BIOTECH LTD. 148 HENDERSON MORLEY PLC 148 ICHOR MEDICAL SYSTEMS INC. 149 IGXBIO INC. 150 IMMUNOMIC THERAPEUTICS INC. 150 IMMUNOVACCINE INC. 151 IN CELL ART 152 INDIAN IMMUNOLOGICALS 153 INOVIO 154 INVIVOGEN 156 JUVARIS BIOTHERAPEUTICS INC. 156 LENTIGEN CORP. 157 MANNKIND CORP. 157 MERCK 158 TABLE 78 MERCK VACCINE PRODUCTS 159 MERIAL LTD. 159 MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE 160 MOLOGEN AG 160 MULTIMERIC BIOTHERAPEUTICS INC. 161 NATURE TECHNOLOGY CORP. 162 NIH VACCINE RESEARCH CENTER 162 NOVARTIS 163 OXFORD BIOMEDICA PLC 164 PFIZER 164 PLASMIDFACTORY GMBH & CO. 165 PROFECTUS BIOSCIENCES INC. 166 QED BIOSCIENCE INC. 167 SANOFI-AVENTIS 168
8 STATENS SERUM INSTITUT 169 SUPRATEK PHARMA 170 TOLERION INC. 170 VALNEVA SE 171 VAXGEN INC. 171 VAXIION THERAPEUTICS INC. 172 VAXONCO INC. 173 VGX PHARMACEUTICALS LLC 173 VGXI INC. 174 VICAL INC. 174 VIROMED CO. LTD. 175 XENETIC BIOSCIENCE INC. 176 TABLE 79 COMPANIES WITH ACTIVE DNA VACCINE CLINICAL TRIALS 176
9 LIST OF TABLES TABLE HEADING TABLE A SCOPE OF REPORT 3 SUMMARY TABLE GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, TABLE 1 SCOPE OF THIS REPORT 11 TABLE 2 GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS) TABLE 3 GLOBAL VALUE OF HUMAN DNA VACCINE MARKET BY INDICATION, TABLE 4 DNA VACCINE INDUSTRY GROWTH DRIVING FORCES 13 TABLE 5 LIFE CYCLE STAGE OF VACCINE TYPES 14 TABLE 6 COMMERCIAL STATUS OF DNA VACCINES 14 TABLE 7 DNA VACCINE INDUSTRY STRUCTURE 15 TABLE 8 DNA VACCINE HISTORY 19 TABLE 9 COMPONENTS OF THE IMMUNE SYSTEM 20 TABLE 10 VACCINE TYPES 23 TABLE 11 TECHNOLOGY LIFE CYCLE STAGE OF VACCINE TYPES 24 TABLE 12 CHANGING VACCINE PARADIGM 26 TABLE 13 ADVANTAGES AND DISADVANTAGES OF DNA VACCINES 27 TABLE 14 EMERGING COMPETITIVE LANDSCAPE FOR DNA VACCINES 31 TABLE 15 CANCER VACCINE TYPES 32 TABLE 16 TECHNOLOGY DRIVERS FOR DNA VACCINE VALUE CHAIN 34 TABLE 17 PLASMID DESIGN OBJECTIVES 35 TABLE 18 WAYS TO OPTIMIZE MAMMALIAN GENE EXPRESSION IN PLASMID DNA 36 TABLE 19 DNA PLASMID QUALITY COMPARISON 38 TABLE 20 COMPARISON OF DNA DELIVERY TECHNOLOGIES 39 TABLE 21 IN VIVO VIRAL VECTOR TECHNOLOGIES COMPARED 44 TABLE 22 DNA VACCINE ADJUVANT TECHNOLOGIES 46 TABLE 23 TECHNOLOGY NEEDS FOR DNA VACCINES 48 TABLE 24 DNA VACCINE DEVELOPMENT FLOW SHEET 52 TABLE 25 DNA VACCINE PRECLINICAL DEVELOPMENT STEPS 53 TABLE 26 DNA VACCINES CLINICAL TRIALS SUMMARY BY STARTING YEAR, AS OF APRIL 2014 TABLE 27 DNA VACCINE CLINICAL PHASE I TRIALS SUMMARY, AS OF APRIL TABLE 28 DNA VACCINE CLINICAL PHASE I/II TRIALS SUMMARY, AS OF APRIL TABLE 29 DNA VACCINE CLINICAL PHASE II TRIALS SUMMARY, AS OF APRIL TABLE 30 DNA VACCINE CLINICAL PHASE II/III TRIALS SUMMARY, AS OF APRIL TABLE 31 DNA VACCINE CLINICAL PHASE III TRIALS SUMMARY, AS OF APRIL TABLE 32 DNA VACCINE CLINICAL PHASE IV TRIALS SUMMARY, AS OF APRIL TABLE 33 DNA VACCINE CANCER CLINICAL TRIALS SUMMARY, AS OF APRIL TABLE 34 INFECTIOUS DISEASES DNA VACCINES CLINICAL TRIALS, AS OF APRIL 2014 TABLE 35 INFECTIOUS DISEASES DNA VACCINES CLINICAL TRIALS, AS OF APRIL 2014 TABLE 36 VACCINE INDUSTRY STRUCTURAL SHIFTS 82 TABLE 37 VACCINE INDUSTRY STRUCTURE: TRADITIONAL VERSUS EMERGING 83 TABLE 38 COMPARISON OF VACCINES AND PHARMACEUTICALS BUSINESSES 85 TABLE 39 DNA VACCINE INDUSTRY COMPETITOR POSITION 87 TABLE 40 LARGE PHARMA VACCINE COMPANY STRATEGIC FOCUS
10 TABLE HEADING TABLE 41 INTEGRATED BIOTECHNOLOGY COMPANY STRATEGIC FOCUS 90 TABLE 42 INTEGRATED BIOTECHNOLOGY COMPANY STRATEGIC MARKET FOCUS 91 TABLE 43 SPECIALIZED BIOTECHNOLOGY COMPANY STRATEGIC FOCUS 93 TABLE 44 ASTELLAS PHARMA INC. OPEN CLINICAL TRIALS, AS OF APRIL TABLE 45 BAVARIAN NORDIC OPEN CLINICAL TRIALS, AS OF APRIL TABLE 46 BEIJING CENTER FOR DISEASE CONTROL AND PREVENTION; MUNICIPAL SCIENCE & TECHNOLOGY COMMISSION OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 47 CITY OF HOPE MEDICAL CENTER, NATIONAL CANCER INSTITUTE (NCI) OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 48 DYNAVAX TECHNOLOGIES CORPORATION OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 49 GLAXOSMITHKLINE OPEN CLINICAL TRIALS, AS OF APRIL TABLE 50 IMPERIAL COLLEGE LONDON OPEN CLINICAL TRIALS, AS OF APRIL TABLE 51 MERCK SHARP & DOHME OPEN CLINICAL TRIALS, AS OF APRIL TABLE 52 NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 53 NATIONAL TAIWAN UNIVERSITY HOSPITAL OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 54 SANOFI OPEN CLINICAL TRIALS, AS OF APRIL TABLE 55 SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER OPEN CLINICAL TRIALS, AS OF APRIL 2014 TABLE 56 U.S. ARMY MEDICAL RESEARCH OPEN CLINICAL TRIALS, AS OF APRIL TABLE 57 UNIVERSITY OF COLORADO OPEN CLINICAL TRIALS, AS OF APRIL TABLE 58 UNIVERSITY OF OXFORD OPEN CLINICAL TRIALS, AS OF APRIL TABLE 59 UNIVERSITY OF WISCONSIN OPEN CLINICAL TRIALS, AS OF APRIL TABLE 60 INDUSTRY ACQUISITIONS AND MERGERS, TABLE 61 DNA VACCINE STRATEGIC ALLIANCES 102 TABLE 62 DNA VACCINE INDUSTRY GROWTH DRIVING FORCES 105 TABLE 63 GLOBAL VALUE OF PHARMACEUTICAL MARKET BY TYPE, THROUGH 2019 ($ MILLIONS) TABLE 64 GLOBAL VALUE OF DNA VACCINES BY END USE, THROUGH 2019 ($ MILLIONS) TABLE 65 GLOBAL VALUE OF DNA VACCINES RESEARCH TOOLS MARKET BY APPLICATION, TABLE 66 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY APPLICATION, TABLE 67 DNA VACCINE ALLERGY MARKET OPPORTUNITIES 110 TABLE 68 CAUSE OF DEATH, WORLDWIDE, 2004 AND 2030 (% OF ALL DEATHS) 111 TABLE 69 GLOBAL VALUE OF CANCER CLINICAL DNA VACCINES BY INDICATION, TABLE 70 DNA VACCINE CANCER MARKET OPPORTUNITIES 112 TABLE 71 GLOBAL VALUE OF INFECTIOUS DISEASE CLINICAL DNA VACCINES MARKET BY INDICATION, TABLE 72 GLOBAL VALUE OF ANIMAL HEALTH CLINICAL DNA VACCINES MARKET, BY INDICATION, TABLE 73 GLOBAL VALUE OF BIODEFENSE CLINICAL DNA VACCINES MARKET, BY END USE, TABLE 74 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY DELIVERY TECHNOLOGY,
11 TABLE HEADING TABLE 75 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY VACCINE FORMAT, TABLE 76 GLOBAL VALUE OF CLINICAL DNA VACCINES MARKET BY FUNCTION, TABLE 77 GLOBAL VALUE OF DNA VACCINES MARKET, BY GEOGRAPHICAL REGION, TABLE 78 MERCK VACCINE PRODUCTS 159 TABLE 79 COMPANIES WITH ACTIVE DNA VACCINE CLINICAL TRIALS
12 LIST OF FIGURES FIGURE TITLE SUMMARY FIGURE GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, ($ MILLIONS) FIGURE 1 EVOLUTION OF VACCINE TECHNOLOGIES 22 FIGURE 2 MECHANISM OF ACTION OF A DNA VACCINE 25 FIGURE 3 SAFETY AND EFFICACY PROFILE OF DNA VERSUS VIRAL-VECTOR VACCINES 29 FIGURE 4 DNA VACCINE FUNCTION AND MARKET SCOPE 29 FIGURE 5 DNA VACCINE TECHNOLOGY VALUE CHAIN 33 FIGURE 6 CONVENTIONAL AND PLASMID DNA VACCINE PRODUCTION PROCESS 38 FIGURE 7 EP PROCESS SCHEMATIC 41 FIGURE 8 STRATEGIES FOR TARGETING DENDRITIC CELLS 46 FIGURE 9 FUTURE VACCINE CLINICAL TRIALS OVERVIEW 53 FIGURE 10 MARKETING OF APPROVED VACCINES IN THE UNITED STATES, 2014 (%) 84 FIGURE 11 DNA VACCINE COMMERCIAL VALUE CHAIN 89 FIGURE 12 DNA VACCINE STRATEGIC MARKET GRID 109 7
CANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
CANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS PHM173A January 2015 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-008-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationVaccine Technologies and Global Markets
A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious
More informationNUTRACEUTICALS: GLOBAL MARKETS
NUTRACEUTICALS: GLOBAL MARKETS FOD013E November 2014 Natraj Pandal Project Analyst ISBN: 1-56965-992-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the
More informationINCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS
INCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS PHM162A February 2015 Kim Lawson Project Analyst ISBN: 1-62296-047-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA
More informationGRNVAC DCVax-Brain AGS Glionix CYT004-MelQbG CDX-110 (PF ) GI TABLE 23 OCCURRENCE OF
CHAPTER ONE: INTRODUCTION.1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 3 AUTHOR S CREDENTIALS...
More informationTABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationGLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationINTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationMEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationCHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
More informationORGANIC FOODS AND BEVERAGES: GLOBAL MARKETS
ORGANIC FOODS AND BEVERAGES: GLOBAL MARKETS FOD067A June 2014 Natraj Pandal Project Analyst ISBN: 1-56965-851-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
More informationBOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS
BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BIO022G August 2015 Kim Lawson Project Analyst ISBN: 1-62296-134-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationTHERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE
THERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE PHM125A January 2013 Willem Westra Project Analyst ISBN: 0-89336-715-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215,
More informationGASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst
GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS HLC174A October 2015 Usha Nagavarapu Project Analyst ISBN: 1-62296-167-6 BCC Research 49 Walnut Park, Building 2 Wellesley,
More informationLIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS
LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS BIO150A January 2016 John Bergin Project Analyst ISBN: 1-62296-224-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationJAK AND PI3K SIGNALING PATHWAY MARKETS
JAK AND PI3K SIGNALING PATHWAY MARKETS PHM168A April 2014 Shalini Shahani Dewan Project Analyst ISBN: 1-56965-793-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationU.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE
U.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE FOD029E January 2015 Mary Anne Crandall Project Analyst ISBN: 1-62296-005-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationHuman Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2016
Report Information More information from: https://www.wiseguyreports.com/reports/685904-human-papillomavirus-hpv-associated-cancerpipeline-review-h2-2016 Human Papillomavirus (HPV) Associated Cancer -
More informationPrevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March 2017 Usha Nagavarapu Report # PHM113B Table of Contents Chapter 1 Introduction... 1 Introduction... 1 Study goals and
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS
ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS PHM119B September 2016 Anuj Pathak Project Analyst ISBN: 1-62296-345-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationTable Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
More informationThe National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare
More informationOrgan Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationBIOPSY DEVICES: TECHNOLOGY AND GLOBAL MARKETS
BIOPSY DEVICES: TECHNOLOGY AND GLOBAL MARKETS HLC171B March 2016 Yojana Jeevane Project Analyst ISBN: 1-62296-257-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationInfluenza Vaccination Market Research Report Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1621 Influenza Vaccination Market Research Report Global Forecast till 2023 Report / Search Code: MRFR/HC/1090-HCRR
More informationRADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS
RADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS HLC176A February 2015 Neha Maliwal Project Analyst ISBN: 1-62296-043-2 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationTHYROID HORMONE THERAPY TABLE 21 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR FIGURE 4 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ANALYST S CREDENTIALS...
More informationGLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS HLC029D January 2013 Paul Evers Project Analyst ISBN: 0-89336-238-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationREFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major
More informationHuman Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016
Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business
More informationPHM029D - Antifungal Drugs: Technologies and Global Markets TABLE OF CONTENTS
TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY GOALS AND OBJECTIVES 1 REASONS FOR DOING THIS STUDY 1 INTENDED AUDIENCE 2 SCOPE OF REPORT 2 METHODOLOGY 2 INFORMATION SOURCES 2 ANALYST CREDENTIALS 3 RELATED
More informationREGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationANESTHESIA AND RESPIRATORY DEVICES: GLOBAL MARKETS. HLC167A February Vijay Laxmi Project Analyst ISBN:
ANESTHESIA AND RESPIRATORY DEVICES: GLOBAL MARKETS HLC167A February 2014 Vijay Laxmi Project Analyst ISBN: 1-56965-704-1 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationCHAPTER FOUR: MARKET SIZE AND GROWTH SLEEP MEDICATIONS MARKET PRESCRIPTION... 40
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR STUDY... 1 SCOPE OF STUDY... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS... 2 BCC
More informationRENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS BIO138A January 2015 Cheng-Yuk Lee Project Analyst ISBN: 1-62296-003-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 024 USA 866-285-7215 (toll-free
More informationHypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research
Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to 2024 - Hexa Research " The global hypodermic needles market was estimated at USD 2,568.7 million in 2016. The primary
More informationMedical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health Authority
DNA Vaccines The Future of Travel Health Vaccines? Or Just a Bad Idea? Dr. Pierre J. Plourde Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health
More informationNew study: Tuberculosis vaccine treatment market research forecast to 20...
1 of 9 10-Dec-2016 3:11 PM Home Technology Company Directory Share your news Membership Market Research Advertise About Login Medical Health & Life Science Research News New study: Tuberculosis vaccine
More informationHow and Why Vaccines Are Developed by Industry. Stanley A. Plotkin
How and Why Vaccines Are Developed by Industry Stanley A. Plotkin Merieux 2012 1 Why Vaccines are Different than Drugs 1) Given to healthy people, high safety required 2) Larger governmental role 3) Low
More informationCytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019
Reference Code: GDHC504PRT Publication Date: January 2013 Cytomegalovirus Infections: Key Metrics in Seven Major Pharmaceutical Markets 2012 Epidemiology* Prevalent population (CMV prevalent cases in general
More informationGLYCOBIOLOGY: GLOBAL MARKETS FOR DIAGNOSTICS AND THERAPEUTICS
GLYCOBIOLOGY: GLOBAL MARKETS FOR DIAGNOSTICS AND THERAPEUTICS BIO153A September 2016 Marianna Tcherpakov Project Analyst ISBN: 1-62296-358-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationPioneering vaccines that transform lives.
Pioneering vaccines that transform lives. Immunomic Therapeutics, Inc. LAMP-Vax for General Oncology Presentation Outline 1. Immunomic Therapeutics: corporate overview 2. Unmet need in cancer immunotherapy
More informationSickle-cell Anemia Therapeutics Market in the US
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal
More informationGlobal Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage
Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country: Opportunities and Forecast (2016-2021)
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationMICROELECTRONIC MEDICAL IMPLANTS: PRODUCTS, TECHNOLOGIES & OPPORTUNITIES
MICROELECTRONIC MEDICAL IMPLANTS: PRODUCTS, TECHNOLOGIES & OPPORTUNITIES HLC016E May 2016 Andrew McWilliams Project Analyst ISBN: 1-62296-295-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationChina Vaccine Market Report,
China Market Report, 2007-2009 China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationThe Crisis in. Vaccine Development
The Crisis in Vaccine Development Stanley A. Plotkin 1 Annecy 2015 The Evolution of the Vaccine Industry 1. 18 th -19 th Centuries Pioneers 2. 1900-1950 National Producers 3. 1960-1980 Globalization 4.
More informationADULT ENTERAL NUTRITION PARENTERAL NUTRITION U.S. REGULATORY ENVIRONMENT THE INFANT FORMULA ACT OF The 1986 Amendments
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS...
More informationGlobal Skin Cancer Diagnosis and Therapeutics Market Research and Forecast
Report Information More information from: https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeuticsmarket-research Global Skin Cancer Diagnosis and Therapeutics Market
More informationInnovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays
About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular
More informationREFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast
More informationOncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
More informationChina Human Vaccine Industry Report, May 2012
China Human Vaccine Industry Report, 2011-2012 May 2012 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight and
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationIrritable Bowel Syndrome - Pipeline Review, H2 2016
Report Information More information from: https://www.wiseguyreports.com/reports/752817-irritable-bowel-syndrome-pipeline-review-h2-2016 Irritable Bowel Syndrome - Pipeline Review, H2 2016 Report / Search
More informationOVER-THE-COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS: GLOBAL MARKETS
OVER-THE-COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS: GLOBAL MARKETS PHM050B February 2014 Anand Gijare Project Analyst ISBN: 1-56965-690-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationREFERENCE CODE GDHC334DFR PUBLICAT ION DATE J ANU ARY 2014 ENGERIX-B (PROPHYLACTIC HEPATITIS B VIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC334DFR PUBLICAT ION DATE J ANU ARY 2014 ENGERIX-B (PROPHYLACTIC HEPATITIS B VIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary The table below provides a summary
More informationThe Role of Pharmaceutical Industry in Vaccine R&D
The Role of Pharmaceutical Industry in Vaccine R&D Jean-Paul Prieels 12/03/13 1 The Players : 5 majors share over 90% of the global vaccine market 2 new entrants : J&J (Crucell) and Takeda 12/03/13 2 Where
More informationContraceptives: Technologies and Global Markets
A BCC Research Healthcare Report HLC085A Use this report to: Learn how shifting demographic and sociological factors such as population growth, proportion of young population, and perceptions about family
More informationREFERENCE CODE GDHC68PIDR PUBLICATION DATE JANUARY 2014 PROPHYLACTIC HEPATITIS B VIRUS VACCINES - GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC68PIDR PUBLICATION DATE JANUARY 2014 PROPHYLACTIC HEPATITIS B VIRUS VACCINES - GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Prophylactic HBV Vaccines: Key Metrics
More informationGlobal Myasthenia Gravis Market: Size, Trends & Forecasts ( ) August 2017
Global Myasthenia Gravis Market: Size, Trends & Forecasts (2017-2021) August 2017 Global Myasthenia Gravis Market Scope of the Report The report titled Global Myasthenia Gravis Market: Size, Trends & Forecasts
More informationMedicago: transforming the approach to vaccines and protein-based therapeutics. Bruce D. Clark PhD President & CEO September 27, 2017
Medicago: transforming the approach to vaccines and protein-based therapeutics Bruce D. Clark PhD President & CEO September 27, 2017 Medicago Overview Focus Manufacturing technology Vaccine technology
More informationChina Human Vaccine Industry Report, July 2017
China Human Vaccine Industry Report, 2017-2021 2021 July 2017 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationJEAN-CHRISTOPHE AUDONNET
JEAN-CHRISTOPHE AUDONNET Recombinant Veterinary Vaccines Overview of Progress in the past 30 years and Future Trends Jean-Christophe AUDONNET DVM, Ph.D. Merial R&D OUTLINE OF THE TALK 01 02 ORIGIN AND
More informationU.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 Hexa Research
U.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 Hexa Research "U.S. Medical Cannabis Market Size Worth USD 19.48 Billion By 2024." 27 December
More informationDiabetic Peripheral Neuropathy - Pipeline Review, H2 2017
Published on Drug Pipeline (https://www.drugpipeline.net) Home > Diabetic Peripheral Neuropathy - Pipeline Review, H2 2017 Diabetic Peripheral Neuropathy - Pipeline Review, H2 2017 Publication ID: GMD0717059
More informationBioDiem to present at Hong Kong biotech investment forum
ASX Announcement BIODIEM LTD ABN 20 096 845 993 Suite 3, Level 11, 470 Collins Street, Melbourne, Victoria, 3000 Australia Phone: +613 9613 4100 Web: www.biodiem.com BioDiem to present at Hong Kong biotech
More informationNovember 2012 Volume: TMRCHPV CYTOLOGY AND HPV TESTING WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications November 2012 Volume: TMRCHPV12-1101 CYTOLOGY AND HPV TESTING WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE
More informationREFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - Executive Summary Menomune: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU
More informationMedical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research
Medical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationCHAPTER FIVE: COMMERCIAL APPLICATIONS TABLE 12 COMMERCIAL AMINO ACIDS BY USE... 35
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS...
More informationCURRENT DEVELOPMENT IN PEDIATRIC VACCINATION
Univ.-Prof. Dr. med. Heinz-J. SCHMITT Senior Medical Director, Pfizer Vaccines Europe Thessaloniki, February 20th, 2018 CURRENT DEVELOPMENT IN PEDIATRIC VACCINATION Selected Case Fatality Rates Germany,
More informationChina Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationCountry Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
More informationGlobal Oil Softgel Capsules Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oil Softgel Capsules Market Research Report 2016 Global Oil Softgel Capsules Market Research Report 2016
More informationBiotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.
More informationForward Looking Statements
Slide title Forward Looking Statements This presentation may contain forward looking statements with respect to the financial condition, results and business achievements/performance of Biotron Limited
More informationCOPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
More informationREFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) Executive Summary Nimenrix: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan
More informationVACCINE ENGINEERING Dr.T.V.Rao MD
VACCINE ENGINEERING Dr.T.V.Rao MD DR.T.V.RAO MD 1 HISTORICAL PICTURE OF VACCINATION DR.T.V.RAO MD 2 WHAT IS A VACCINE A vaccine is any preparation intended to produce immunity to a disease by stimulating
More informationEU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission
EU support to hepatitis research Anna Lönnroth Sjödén Health Research DG Research - European Commission Hepatitis B and C Summit, Brussels, 15 October 2010 1 Main Objectives: to improve quality of life
More informationImage of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval
More informationChina Human Vaccine Industry Report, Mar. 2015
China Human Vaccine Industry Report, 2015-2018 Mar. 2015 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationVisceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research
Visceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research The global visceral pain market size was estimated at USD 9.51 billion in 2016 and is expected to
More informationOur research for you. German Equity Forum November 2011
Our research for you. German Equity Forum 21-23 November 2011 Disclaimer Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as
More informationTABLE OF CONTENTS. HLC102A - Continuous Glucose Monitoring (CGM): Technologies and Global Markets
TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY GOALS AND OBJECTIVES 1 REASONS FOR DOING THIS STUDY 1 CONTRIBUTIONS TO THE STUDY AND INTENDED AUDIENCE 1 SCOPE AND FORMAT 1 METHODOLOGY AND INFORMATION
More informationEPIDEMIOLOGICAL STUDIES
EPIDEMIOLOGICAL STUDIES EPIDEMIOLOGIC STUDIES EPIDEMIOLOGIC STUDIES 8 Clinical Trial sites in Brasil (NICHD) Transfusion recipient study (NHLBI) Prospective study in Brasil (Yale) Natural history population
More informationAntifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles
Antifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin,
More informationMEDICAL ULTRASOUND DEVICES: TECHNOLOGIES AND GLOBAL MARKETS
MEDICAL ULTRASOUND DEVICES: TECHNOLOGIES AND GLOBAL MARKETS IAS040B October 2016 Paul Taylor Project Analyst ISBN: 1-62296-372-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationSleep apnea devices Market Research Report- Global Forecast To 2022
Report Information More information from: https://www.marketresearchfuture.com/reports/2061 Sleep apnea devices Market Research Report- Global Forecast To 2022 Report / Search Code: MRFR/HC/1529-HCRR Publish
More informationGlobal Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )
Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country
More informationGlobal Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
More informationThis report was prepared on behalf of the HIV Vaccines and Microbicides Resource Tracking Working Group by Gabrielle Lamourelle (IAVI), Polly Harrison
TRACKING FUNDING FOR PREVENTIVE HIV VACCINE RESEARCH & DEVELOPMENT: ESTIMATES OF ANNUAL INVESTMENTS AND EXPENDITURES 2000 TO 2005 JUNE 2005 HIV Vaccines and Microbicides Resource Tracking Working Group
More information